FDA Recalls Neonatal TPN Starter Bags for Sterility Concerns
Central Admixture Pharmacy Services recalls 747 bags of Neonatal TPN Starter Bags due to FDA sterility concerns. Products were distributed nationwide across the USA.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product (intravenous nutrition for vulnerable neonates) where no illnesses or injuries have been reported. The lack of sterility assurance in an injectable product intended for vulnerable patients represents significant potential for infection.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 747 bags of Neonatal TPN Starter Bag (Amino Acids [Trophamine] 4% / Dextrose 10% with Calcium and Heparin, 250 mL per bag, NDC 71285-0422-1) distributed nationwide. The recall was initiated following an FDA inspection that called into question the sterility assurance of these intravenous nutrition products.
The affected lots with their expiration dates are: 37-893819 (04/28/2023), 37-894702 (04/30/2023), 37-894710 (04/30/2023), 37-895215 (05/04/2023), 37-897282 (05/12/2023), 37-897921 (05/13/2023), 37-898309 (05/14/2023), 37-899199 (05/19/2023), and 37-900058 (05/21/2023). The products are manufactured by Central Admixture Pharmacy Services, Inc., located at 6580 Snowdrift Road, Allentown, Pennsylvania 18106.
Healthcare providers and patients should verify whether they have received any of these recalled products. These are prescription-only products intended for intravenous use in neonatal patients. If any of the affected lots have been dispensed, they should not be used. Patients and healthcare providers should contact their healthcare provider or the manufacturer with questions or concerns.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0422-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Parenteral Nutrition
- Affected units
- 747
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (17)
- Lot # 37-893819
- Exp 04/28/2023
- 37-894702
- 37-894710
- Exp 04/30/2023
- 37-895215
- Exp 05/04/2023
- 37-897282
- Exp 05/12/2023
- 37-897921
- Exp 05/13/2023
- 37-898309
- Exp 05/14/2023
- 37-899199
- Exp 05/19/2023
- 37-900058
- Exp 05/21/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 108 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 108 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighEphedrine Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighFentanyl injectable syringes recalled nationwide for sterility assurance failure
FDA (Drugs) · 2023-10-11
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- HighNeonatal TPN Starter Bags Recalled Due to Sterility Validation Concerns
FDA (Drugs) · 2023-08-09
- HighFDA Recalls Neonatal TPN Starter Bag for Lacking Sterility Assurance
FDA (Drugs) · 2023-08-09
- HighNeonatal TPN Starter Bags recalled due to sterility assurance failure
FDA (Drugs) · 2023-08-09
- HighNeonatal TPN Starter Bags Recalled for Sterility Assurance Gaps
FDA (Drugs) · 2023-09-06
- HighNeonatal TPN Bags Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-08-09
- HighNeonatal TPN Starter Bag recalled for sterility assurance concerns
FDA (Drugs) · 2023-09-06